March 9, 2018 Conference

  


TEST
Title
Advances in Gene Therapy


Author
Dr. Eric Pierce, Ocular Genomics Institute/MEEI (Presenter)
Abstract

The recent FDA approval of gene augmentation therapy for RPE65-associated retinal degeneration suggests that gene and genetically directed therapies have great potential for the treatment of inherited eye disorders, such as inherited retinal degenerations (IRDs).  The different therapeutic approaches currently being studied for the treatment of IRDs will be discussed.  The status clinical trials of gene and genetic therapies for IRDs will be reviewed.

Video